Generic Drugs Market Research Report Information by Type (Simple Generics and Super Generics), by Brand (Pure Generic and Branded Generic), by Indication (Central Nervous System (CNS), Cardiovascular, Urology, Oncology, Respiratory, and Others), by Route

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,950	160 Pages	Market Research Future	August, 2024	RESFT19210280

Best Price Guarantee
Price	from $4,950
Length	160 Pages
Publisher	Market Research Future
Published Date	August, 2024
SKU	RESFT19210280

Generic Drugs Market Research Report Information by Type (Simple Generics and Super Generics), by Brand (Pure Generic and Branded Generic), by Indication (Central Nervous System (CNS), Cardiovascular, Urology, Oncology, Respiratory, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032

In 2023, the generic drug market was estimated to be worth USD 410.60 billion. According to projections, the generic drugs market would expand at a compound annual growth rate (CAGR) of 7.85% from USD 437.90 billion in 2024 to USD 874.36 billion by 2032. The primary drivers propelling the growth of the global generic medicine market are increased strategic initiatives by market competitors and rising rates of chronic diseases worldwide. On the other hand, market participants' voluntary product recalls are anticipated to impede the expansion of the worldwide market. Nonetheless, it is projected that the market will benefit greatly from investments made in generic medicine research and development (R&D).

Globally, the prevalence of chronic diseases is rising, which is driving the generic medication industry to grow significantly. Patients and healthcare providers are increasingly turning to generic pharmaceuticals as a result of the rising prevalence of problems including cancer, neurological disorders, cardiovascular diseases, inflammatory diseases, and others. This is because there is a greater need for affordable treatment choices.

Insights on Market Segments
Super generics and basic generics are included in the market segmentation of generic drugs depending on kind.
Pure generic and branded generic are included in the market segmentation of generic drugs depending on brand.
Based on indication, the generic drug market is divided into segments for the central nervous system (CNS), cardiology, urology, cancer, respiratory, and other areas.

Regional Perspectives
The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. The growing need for generic drugs in hospitals and other medical settings, technological improvements, and the increased incidence of chronic illnesses are all contributing to the substantial expansion of the generic drug market in North America.

Due to a strong healthcare system and partnerships and cooperation between industry participants, research organizations, and healthcare providers, the European generic drug market has the second-largest market share. Additionally, the generic drug provider in Germany is said to have the most market share, while the generic drug provider in France is anticipated to have the quickest rate of growth in the European region.

From 2023 to 2032, the Asia-Pacific generic drug market is anticipated to grow at the quickest rate due to the rise in chronic medical conditions like cancer, diabetes, and cardiovascular diseases, as well as rising healthcare costs and investments in R&D. Furthermore, India Generic Drugs is anticipated to develop at the highest rate in the Asia-Pacific region, while China Generic Drugs had the greatest market share.

Principal Players
Important players in the generic drug market are Aspen Holdings (South Africa), Teva Pharmaceuticals Industries Ltd. (Israel), Cipla Ltd. (India), Fresenius SE & Co. KGaA (Germany), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Lupin Pharmaceuticals, Inc. (India), Endo International plc (Ireland), Aurobindo Pharma (India), and Aspen Holdings (South Africa).

1 Executive Summary
2 Market Introduction: 2.1 Definition; 2.2 Scope Of The Study; 2.3 Research Objective; 2.4 Market Structure
3 Research Methodology: 3.1 Overview; 3.2 Data Flow; 3.2.1 Data Mining Process; 3.3 Purchased Database:; 3.4 Secondary Sources:; 3.4.1 Secondary Research Data Flow:; 3.5 Primary Research:; 3.5.1 Primary Research Data Flow:; 3.5.2 Primary Research: Number Of Interviews Conducted; 3.5.3 Primary Research: Regional Coverage; 3.6 Approaches For Market Size Estimation:; 3.6.1 Revenue Analysis Approach; 3.7 Data Forecasting; 3.7.1 Data Forecasting Type; 3.8 Data Modeling; 3.8.1 Microeconomic Factor Analysis:; 3.8.2 Data Modeling:; 3.9 Teams And Analyst Contribution
4 Market Dynamics: 4.1 Introduction; 4.2 Drivers; 4.2.1 Increasing Incidences Of Chronic Diseases Across The Globe; 4.2.2 Rising Strategic Initiatives By Market Players; 4.3 Restraints; 4.3.1 Voluntary Product Recalls From Market Players; 4.4 Opportunity; 4.4.1 Invesmtent On Research & Development (R&D) For Generic Medicine
5 Market Factor Analysis: 5.1 Porter's Five Forces Model; 5.1.1 Threat Of New Entrants; 5.1.2 Bargaining Power Of Suppliers; 5.1.3 Threat Of Substitutes; 5.1.4 Bargaining Power Of Buyers; 5.1.5 Intensity Of Rivalry; 5.2 Impact Of Covid-19 On The Global Generic Drugs Market; 5.3 Trends In Developments Of Individual Markets (Eu, Usa, India, China, Other); 5.4 Trends In The Development Of Therapeutic Areas; 5.5 Trends In Manufacturing Sites; 5.6 Trends In New Technological Platforms For Drugs; 5.7 Trends In Ip; 5.8 Trends In Quality Requirements; 5.9 Trends In Regulatory Requirements
6 Global Generic Drugs Market, By Type: 6.1 Overview; 6.2 Simple Generics; 6.3 Super Generics
7 Global Generic Drugs Market, By Brand: 7.1 Overview; 7.2 Pure Generic; 7.3 Branded Generic
8 Global Generic Drugs Market, By Indication: 8.1 Overview; 8.2 Central Nervous System (Cns); 8.3 Cardiovascular; 8.4 Urology; 8.5 Oncology; 8.6 Respiratory; 8.7 Others
9 Global Generic Drugs Market, By Route Of Administration: 9.1 Overview; 9.2 Oral; 9.3 Topical; 9.4 Parenteral; 9.5 Others
10 Global Generic Drugs Market, By Distribution Channel: 10.1 Overview; 10.2 Hospital Pharmacy; 10.3 Retail Pharmacy; 10.4 Online Pharmacy
11 Global Generic Drugs Market, By Region: 11.1 Overview; 11.2 North America; 11.2.1 Us; 11.2.2 Canada; 11.3 Europe; 11.3.1 Germany; 11.3.2 France; 11.3.3 Uk; 11.3.4 Italy; 11.3.5 Spain; 11.3.6 Rest Of Europe; 11.4 Asia-pacific; 11.4.1 China; 11.4.2 India; 11.4.3 Japan; 11.4.4 South Korea; 11.4.5 Australia; 11.4.6 Rest Of Asia-pacific; 11.5 Rest Of The World; 11.5.1 Middle East & Africa; 11.5.2 Latin America
12 Competitive Landscape: 12.1 Introduction; 12.2 Market Share Analysis, 2022; 12.3 Competitor Dashboard; 12.4 Public Players Stock Summary; 12.5 Comparative Analysis: Key Players Finanical; 12.6 Key Developments & Growth Strategies; 12.6.1 Product Launch / Product Approval; 12.6.2 Expansion
13 Company Profiles: 13.1 Sun Pharmaceutical Industries Ltd.; 13.1.1 Company Overview; 13.1.2 Financial Overview; 13.1.3 Products Offered; 13.1.4 Key Developments; 13.1.5 Swot Analysis; 13.1.6 Key Strategies; 13.2 Lupin Pharmaceuticals, Inc.; 13.2.1 Company Overview; 13.2.2 Financial Overview; 13.2.3 Products Offered; 13.2.4 Key Developments; 13.2.5 Swot Analysis; 13.2.6 Key Strategies; 13.3 Endo International Plc; 13.3.1 Company Overview; 13.3.2 Financial Overview; 13.3.3 Products Offered; 13.3.4 Key Developments; 13.3.5 Key Strategies; 13.4 Aurobindo Pharma; 13.4.1 Company Overview; 13.4.2 Financial Overview; 13.4.3 Products Offered; 13.4.4 Key Developments; 13.4.5 Key Strategies; 13.5 Aspen Holdings; 13.5.1 Company Overview; 13.5.2 Financial Overview; 13.5.3 Products Offered; 13.5.4 Key Developments; 13.5.5 Key Strategies; 13.6 Cipla Ltd; 13.6.1 Company Overview; 13.6.2 Financial Overview; 13.6.3 Products Offered; 13.6.4 Key Developments; 13.6.5 Swot Analysis; 13.6.6 Key Strategies; 13.7 Novartis Ag; 13.7.1 Company Overview; 13.7.2 Financial Overview; 13.7.3 Products Offered; 13.7.4 Key Developments; 13.7.5 Swot Analysis; 13.7.6 Key Strategies; 13.8 Teva Pharmaceutical Industries Ltd; 13.8.1 Company Overview; 13.8.2 Financial Overview; 13.8.3 Products Offered; 13.8.4 Key Developments; 13.8.5 Swot Analysis; 13.8.6 Key Strategies; 13.9 Fresenius Se & Co. Kgaa; 13.9.1 Company Overview; 13.9.2 Financial Overview; 13.9.3 Products Offered; 13.9.4 Key Developments; 13.9.5 Key Strategies; 13.10 Viatris Inc.; 13.10.1 Company Overview; 13.10.2 Financial Overview; 13.10.3 Products Offered; 13.10.4 Key Developments; 13.10.5 Key Strategies
List Of Tables: Table 1 Qfd Modeling For Market Share Assessment; Table 2 Trends In Regulatory Requirements; Table 3 Global Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 4 Global Generic Drugs Market, For Simple Generics, By Region, 2019–2032 (Usd Billion); Table 5 Global Generic Drugs Market, For Super Generics, By Region, 2019–2032 (Usd Billion); Table 6 Global Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 7 Global Generic Drugs Market, For Pure Generic, By Region, 2019–2032 (Usd Billion); Table 8 Global Generic Drugs Market, For Branded Generic, By Region, 2019–2032 (Usd Billion); Table 9 Global Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 10 Global Generic Drugs Market, For Central Nervous System (Cns), By Region, 2019–2032 (Usd Billion); Table 11 Global Generic Drugs Market, For Cardiovascular, By Region, 2019–2032 (Usd Billion); Table 12 Global Generic Drugs Market, For Urology, By Region, 2019–2032 (Usd Billion); Table 13 Global Generic Drugs Market, For Oncology, By Region, 2019–2032 (Usd Billion); Table 14 Global Generic Drugs Market, For Respiratory, By Region, 2019–2032 (Usd Billion); Table 15 Global Generic Drugs Market, For Others, By Region, 2019–2032 (Usd Billion); Table 16 Global Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 17 Global Generic Drugs Market, For Oral, By Region, 2019–2032 (Usd Billion); Table 18 Global Generic Drugs Market, For Topical, By Region, 2019–2032 (Usd Billion); Table 19 Global Generic Drugs Market, For Parenteral, By Region, 2019–2032 (Usd Billion); Table 20 Global Generic Drugs Market, For Others, By Region, 2019–2032 (Usd Billion); Table 21 Global Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 22 Global Generic Drugs Market, For Hospital Pharmacy, By Region, 2019–2032 (Usd Billion); Table 23 Global Generic Drugs Market, For Retail Pharmacy, By Region, 2019–2032 (Usd Billion); Table 24 Global Generic Drugs Market, For Online Pharmacy, By Region, 2019–2032 (Usd Billion); Table 25 Global Generic Drugs Market, By Region, 2019–2032 (Usd Billion); Table 26 North America: Generic Drugs Market, By Country, 2019–2032 (Usd Billion); Table 27 North America: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 28 North America: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 29 North America: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 30 North America: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 31 North America: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 32 Us: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 33 Us: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 34 Us: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 35 Us: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 36 Us: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 37 Canada: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 38 Canada: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 39 Canada: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 40 Canada: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 41 Canada: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 42 Europe: Generic Drugs Market, By Country, 2019–2032 (Usd Billion); Table 43 Europe: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 44 Europe: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 45 Europe: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 46 Europe: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 47 Europe: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 48 Germany: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 49 Germany: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 50 Germany: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 51 Germany: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 52 Germany: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 53 France: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 54 France: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 55 France: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 56 France: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 57 France: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 58 Uk: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 59 Uk: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 60 Uk: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 61 Uk: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 62 Uk: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 63 Italy: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 64 Italy: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 65 Italy: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 66 Italy: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 67 Italy: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 68 Spain: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 69 Spain: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 70 Spain: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 71 Spain: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 72 Spain: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 73 Rest Of Europe: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 74 Rest Of Europe: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 75 Rest Of Europe: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 76 Rest Of Europe: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 77 Rest Of Europe: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 78 Asia-pacific: Generic Drugs Market, By Country, 2019–2032 (Usd Billion); Table 79 Asia-pacific: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 80 Asia-pacific: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 81 Asia-pacific: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 82 Asia-pacific: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 83 Asia-pacific: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 84 China: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 85 China: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 86 China: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 87 China: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 88 China: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 89 India: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 90 India: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 91 India: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 92 India: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 93 India: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 94 Japan: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 95 Japan: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 96 Japan: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 97 Japan: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 98 Japan: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 99 South Korea: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 100 South Korea: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 101 South Korea: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 102 South Korea: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 103 South Korea: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 104 Australia: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 105 Australia: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 106 Australia: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 107 Australia: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 108 Australia: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 109 Rest Of Asia-pacific: Generic Drugs Market, By Type, 2019–2032 (Usd Billion); Table 110 Rest Of Asia-pacific: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 111 Rest Of Asia-pacific: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 112 Rest Of Asia-pacific: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 113 Rest Of Asia-pacific: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 114 Rest Ot The World: Generic Drugs Market, By Region, 2019–2032 (Usd Billion); Table 115 Rest Of The World: Generic Drugs Market, By Diagnosis & Treatment, 2019–2032 (Usd Billion); Table 116 Rest Of The World: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 117 Rest Of The World: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 118 Rest Of The World: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 119 Rest Of The World: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 120 Middle East & Africa: Generic Drugs Market, By Diagnosis & Treatment, 2019–2032 (Usd Billion); Table 121 Middle East & Africa: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 122 Middle East & Africa: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 123 Middle East & Africa: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 124 Middle East & Africa: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 125 Latin America: Generic Drugs Market, By Diagnosis & Treatment, 2019–2032 (Usd Billion); Table 126 Latin America: Generic Drugs Market, By Brand, 2019–2032 (Usd Billion); Table 127 Latin America: Generic Drugs Market, By Indication, 2019–2032 (Usd Billion); Table 128 Latin America: Generic Drugs Market, By Route Of Administration, 2019–2032 (Usd Billion); Table 129 Latin America: Generic Drugs Market, By Distribution Channel, 2019–2032 (Usd Billion); Table 130 Public Players Stock Summary; Table 131 Comparative Analysis: Key Players Finanical; Table 132 Product Launch/ Product Approval; Table 133 Expansion; Table 134 Sun Pharmaceutical Industries Ltd.: Product Offered; Table 135 Sun Pharmaceutical Industries Ltd.: Key Developments; Table 136 Lupin Pharmaceuticals, Inc.: Product Offered; Table 137 Lupin Pharmaceuticals, Inc.: Key Developments; Table 138 Endo International Plc: Product Offered; Table 139 Endo International Plc: Key Developments; Table 140 Aurobindo Pharma: Product Offered; Table 141 Aurobindo Pharma: Key Developments; Table 142 Aspen Holdings: Product Offered; Table 143 Cipla Ltd.: Products Offered; Table 144 Cipla Ltd.: Key Developments; Table 145 Novartis Ag: Products Offered; Table 146 Novartis Ag: Key Developments; Table 147 Teva Pharmaceutical Industries Ltd: Product Offered; Table 148 Teva Pharmaceutical Industries Ltd: Key Developments; Table 149 Fresenius Se & Co. Kgaa: Product Offered; Table 150 Fresenius Se & Co. Kgaa: Key Developments; Table 151 Viatris Inc.: Product Offered; Table 152 Viatris Inc.: Key Developments
List Of Figures: Figure 1 Global Generic Drugs Market: Structure; Figure 2 Global Generic Drugs Market: Market Growth Factor Analysis (2022-2032); Figure 3 Driver Impact Analysis (2023-2032); Figure 4 Restraint Impact Analysis (2022-2032); Figure 5 Porter's Five Forces Analysis: Global Generic Drugs Market; Figure 6 Global Generic Drugs Market, Type Segment Attractiveness, 2022-2032 (Usd Billion); Figure 7 Global Generic Drugs Market, By Type, 2022 & 2032 (Usd Billion); Figure 8 Global Generic Drugs Market Share (%), By Type, 2022; Figure 9 Global Generic Drugs Market, Brand Segment Attractiveness, 2022-2032 (Usd Billion); Figure 10 Global Generic Drugs Market, By Brand, 2022 & 2032 (Usd Billion); Figure 11 Global Generic Drugs Market Share (%), By Brand, 2022; Figure 12 Global Generic Drugs Market, Indication Segment Attractiveness, 2022-2032 (Usd Billion); Figure 13 Global Generic Drugs Market, By Indication, 2022 & 2032 (Usd Billion); Figure 14 Global Generic Drugs Market Share (%), By Indication, 2022; Figure 15 Global Generic Drugs Market, Route Of Administration Segment Attractiveness, 2022-2032 (Usd Billion); Figure 16 Global Generic Drugs Market, By Route Of Administration, 2022 & 2032 (Usd Billion); Figure 17 Global Generic Drugs Market Share (%), By Route Of Administration, 2022; Figure 18 Global Generic Drugs Market, Distribution Channel Segment Attractiveness, 2022-2032 (Usd Billion); Figure 19 Global Generic Drugs Market, By Distribution Channel, 2022 & 2032 (Usd Billion); Figure 20 Global Generic Drugs Market Share (%), By Distribution Channel, 2022; Figure 21 Global Generic Drugs Market, By Region, 2022 & 2032 (Usd Billion); Figure 22 Global Generic Drugs Market Share (%), By Region, 2022; Figure 23 North Ameica Market Analysis: Generic Drugs Market, 2019-2032 (Usd Billion); Figure 24 North America: Generic Drugs Market, By Country, 2022 & 2032 (Usd Billion); Figure 25 North America: Generic Drugs Market Share (%), By Country, 2022; Figure 26 Europe Market Analysis: Generic Drugs Market, 2019-2032 (Usd Billion); Figure 27 Europe: Generic Drugs Market, By Region, 2022 & 2032 (Usd Billion); Figure 28 Europe: Generic Drugs Market Share (%), By Region, 2022; Figure 29 Asia-pacific Market Analysis: Generic Drugs Market, 2019-2032 (Usd Billion); Figure 30 Asia-pacific: Generic Drugs Market, By Country, 2022 & 2032 (Usd Billion); Figure 31 Asia-pacific: Generic Drugs Market Share (%), By Country, 2022; Figure 32 Rest Of The World Market Analysis: Generic Drugs Market, 2019-2032 (Usd Billion); Figure 33 Rest Ot The World: Generic Drugs Market, By Region, 2022 & 2032 (Usd Billion); Figure 34 Rest Ot The World: Generic Drugs Market Share (%), By Region, 2022; Figure 35 Generic Drugs Market Players: Competitive Analsis, 2022; Figure 36 Competitor Dashboard: Global Generic Drugs Market; Figure 37 Sun Pharmaceutical Industries Ltd.: Financial Overview Snapshot; Figure 38 Sun Pharmaceutical Industries Ltd.: Swot Analysis; Figure 39 Lupin Pharmaceuticals, Inc.: Financial Overview Snapshot; Figure 40 Lupin Pharmaceuticals, Inc.: Swot Analysis; Figure 41 Endo International Plc: Financial Overview Snapshot; Figure 42 Aurobindo Pharma: Financial Overview Snapshot; Figure 43 Aspen Holdings: Financial Overview Snapshot; Figure 44 Cipla Ltd.: Financial Overview; Figure 45 Cipla Ltd.: Swot Analysis; Figure 46 Novartis Ag: Financial Overview Snapshot; Figure 47 Novartis Ag: Swot Analysis; Figure 48 Teva Pharmaceutical Industries Ltd: Financial Overview Snapshot; Figure 49 Teva Pharmaceutical Industries Ltd.: Swot Analysis; Figure 50 Fresenius Se & Co. Kgaa: Financial Overview Snapshot; Figure 51 Viatris Inc.: Financial Overview Snapshot